Protecting First Responders January 9, 2016 • admin • Keeping our heroes safe from the dangers of chemical exposures. Related News Countervail holds initial pre-IND meeting with Neurology Division of the FDA for guidance on development of a neuroprotectant against sub-lethal nerve agent exposure. October 5, 2012 FDA agrees that Countervail’s non-human primate animal model is appropriate for the company’s Animal Rule pivotal GLP study testing February 15, 2017
